PeopleProfileHeaderVectorOne
Marcus Yu

Marcus Yu

Legal Manager

Marcus is a corporate legal manager specialising in public and private M&A, equity capital markets and general corporate and commercial matters.

D +852 2533 2879
M +852 6205 6598

email | vCard

Biography

Languages - English, Chinese
Jurisdiction - Hong Kong

 

Marcus primarily focuses on corporate and commercial transactions. He has assistedin various initial public offerings, de-SPAC transactions, and cross-border mergers and acquisitions. He has experience servicing both issuers and sponsors in initial public offerings and de-SPAC transactions on the Main Board of the Stock Exchange of Hong Kong and the Nasdaq Stock Market.

Marcus completed his Master of Chemistry (MChem) at Pembroke College, University of Oxford and his Juris Doctor (JD) and Postgraduate Certificate in Laws (PCLL) from the University of Hong Kong.

 

Experience

  • A PRC Sponsor – HKEx De-SPAC Merger of Synagistics Limited – Public M&A

    Advised a PRC sponsor on the de-SPAC merger transaction that brought Synagistics Limited (stock code: 2562) public on the HKEx.

  • A PRC Company – Nasdaq De-SPAC Merger– Public M&A

    Advised an education company on its de-SPAC merger to facilitate a contemplated Nasdaq listing.

  • A Vietnamese Company – Nasdaq De-SPAC Merger – Public M&A

    Advised a new energy company on its de-SPAC merger to facilitate a contemplated Nasdaq listing.

  • A Global Education Company – US$700 Million Acquisition - Private M&A

    Advised a global education company on its US$700 million majority stake acquisition by an Asian equity fund.

  • A Multinational Company – PRC Joint Venture Buyout - Private M&A

    Advised a multinational entertainment company in a contemplated buyout of a PRC gaming joint venture from a PRC-based internet technology company.

  • A PRC Sponsor – TYK Medicines IPO under Chapter 18A – Equity Capital Markets

    Advised a PRC sponsor on the initial public offering of TYK Medicines, Inc (stock code: 2410) on the HKEx under Chapter 18A as a biotech listing.

  • A PRC Sponsor - IPO of Qiniu Limited – Equity Capital Markets

    Advised a PRC sponsor on the initial public offering of Qiniu Limited (stock code: 2567) on the HKEx.